Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies
Olson, J. A., Olson, D. M., Sandborg, C., Alexander, S., & Buckingham, B. (2002). Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. PEDIATRICS, 109(3).

Intensive diabetes management in pediatric patients.
Buckingham, B., Bluck, B., & Wilson, D. M. (2001). Intensive diabetes management in pediatric patients. Current Diabetes Reports, 1(1), 11–18.

Analysis: dawn of real-time continuous glucose sensing.
Buckingham, B. (2003). Analysis: dawn of real-time continuous glucose sensing. Diabetes Technology & Therapeutics, 5(3), 381–83.

BIOCHEMICAL-ABNORMALITIES IN VITREOUS OF HUMANS WITH PROLIFERATIVE DIABETIC-RETINOPATHY
SEBAG, J., Buckingham, B., & Charles, M. A. (1992). BIOCHEMICAL-ABNORMALITIES IN VITREOUS OF HUMANS WITH PROLIFERATIVE DIABETIC-RETINOPATHY. ARCHIVES OF OPHTHALMOLOGY, 110(10), 1472–1476.

How should we interpret "real life" conditions.
Eastman, R. C., Chase, H. P., Buckingham, B., Hathout, E., Tamada, J., & Ginsberg, B. (2003). How should we interpret "real life" conditions. Pediatric Diabetes, 4(1), 59-?

Use of the Cygnus GlucoWatch biographer at a diabetes camp
Gandrud, L. M., Paguntalan, H. U., Van Wyhe, M. M., Kunselman, B. L., Leptien, A. D., Wilson, D. M., … Buckingham, B. A. (2004). Use of the Cygnus GlucoWatch biographer at a diabetes camp. PEDIATRICS, 113(1), 108–11.

Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia - Experience of the Diabetes Research in Children Network
Tsalikian, E., Beck, R. W., Tamborlane, W. V., Chase, P., Buckingham, B. A., Weinzimer, S. A., … Winer, K. K. (2004). Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia - Experience of the Diabetes Research in Children Network. DIABETES CARE, 27(3), 722–726.

Use of the GlucoWatch biographer in children and adolescents with diabetes.
Eastman, R. C., Chase, H. P., Buckingham, B., Hathout, E. H., Fuller-Byk, L., Leptien, A., … Pitzer, K. R. (2002). Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatric Diabetes, 3(3), 127–134.

Prevention of type 1a diabetes mellitus*.
Wilson, D. M., & Buckingham, B. (2001). Prevention of type 1a diabetes mellitus*. Pediatric Diabetes, 2(1), 17–24.

Initiation of insulin glargine in children and adolescents with type I diabetes
Tan, C. Y., Wilson, D. M., & Buckingham, B. (2004). Initiation of insulin glargine in children and adolescents with type I diabetes. PEDIATRIC DIABETES, 5(2), 80–86.

Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy study
Mauras, N., Beck, R. W., Ruedy, K. J., KOLLMAN, C., Tamborlane, W. V., Chase, P., … Xing, D. Y. (2004). Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DirecNet) Accuracy study. JOURNAL OF PEDIATRICS, 144(6), 770–775.

Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate
Cagle, A. P., Waguespack, S. G., Buckingham, B. A., Shankar, R. R., & DiMeglio, L. A. (2004). Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate. PEDIATRICS, 114(4), 1091–1095.

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes
Wilson, D. M., Buckingham, B. A., Kunselman, E. L., Sullivan, M. M., Paguntalan, H. U., & Gitelman, S. E. (2005). A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. DIABETES CARE, 28(1), 15–19.

GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.
Tsalikian, E., Kollman, C., Mauras, N., Weinzimer, S., Buckingham, B., Xing, D., … Fiallo-Scharer, R. (2004). GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technology & Therapeutics, 6(5), 559–566.

The extended Kalman filter for continuous glucose monitoring.
Knobbe, E. J., & Buckingham, B. (2005). The extended Kalman filter for continuous glucose monitoring. Diabetes Technology & Therapeutics, 7(1), 15–27.

Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.
Tansey, M. J., Beck, R. W., Buckingham, B. A., Mauras, N., Fiallo-Scharer, R., Xing, D., … Ruedy, K. J. (2005). Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technology & Therapeutics, 7(1), 109–114.

Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes
Fiallo-Scharer, R., Xing, D. Y., Weinzimer, S., Buckingham, B., Mauras, N., Tansey, M., … White, P. C. (2005). Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 90(6), 3387–91.

A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.
Chase, H. P., Beck, R., Tamborlane, W., Buckingham, B., Mauras, N., Tsalikian, E., … Xing, D. (2005). A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care, 28(5), 1101–1106.

Response to nocturnal alarms using a real-time glucose sensor.
Buckingham, B., Block, J., Burdick, J., Kalajian, A., Kollman, C., Choy, M., … Chase, P. (2005). Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technology & Therapeutics, 7(3), 440–47.

Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes
Wysocki, T., Beck, R. W., Tamborlane, W. V., Fiallo-Scharer, R., Tansey, M. J., Weinzimer, S. A., … White, P. C. (2005). Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. DIABETES CARE, 28(8), 1929–1935.

Impact of exercise on overnight glycemic control in - Children with type 1 diabetes mellitus
Tsalikian, E., Mauras, N., Beck, R. W., Tamborlane, W. V., Janz, K. F., Chase, H. P., … White, P. C. (2005). Impact of exercise on overnight glycemic control in - Children with type 1 diabetes mellitus. JOURNAL OF PEDIATRICS, 147(4), 528–534.

Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.
Weinzimer, S. A., Beck, R. W., Chase, H. P., Fox, L. A., Buckingham, B. A., Tamborlane, W. V., … Ruedy, K. J. (2005). Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technology & Therapeutics, 7(5), 675–680.

Hypoglycemia detection, and better yet, prevention, in pediatric patients.
Buckingham, B. (2005). Hypoglycemia detection, and better yet, prevention, in pediatric patients. Diabetes Technology & Therapeutics, 7(5), 792–96.

The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes
Tansey, M. J. (2006). The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. DIABETES CARE, 29(1), 20–25.

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
Sosenko, J. M., Palmer, J. P., Greenbaum, C. J., Mahon, J., Cowie, C., Krischer, J. P., … Skyler, J. S. (2006). Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. DIABETES CARE, 29(3), 643–649.

Vitamin D deficiency in the San Francisco bay area
McAllister, J. C., Lane, A. T., & Buckingham, B. A. (2006). Vitamin D deficiency in the San Francisco bay area. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 19(3), 205–8.

Extended use of a new continuous glucose monitoring system with wireless data transmission in children with type 1 diabetes mellitus
Wong, L. J., Buckingham, B. A., Kunselman, B., Istoc, E., Leach, J., & Purvis, R. (2006). Extended use of a new continuous glucose monitoring system with wireless data transmission in children with type 1 diabetes mellitus. DIABETES TECHNOLOGY & THERAPEUTICS, 8(2), 139–45.

Evaluation of factors affecting CGMS calibration
Buckingham, B. A., Kollman, C., Beck, R. W., Kalajian, A., Fiallo-Scharer, R., Tansey, M. J., … Tamborlane, W. V. (2006). Evaluation of factors affecting CGMS calibration. DIABETES TECHNOLOGY & THERAPEUTICS, 8(3), 318–325.

Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit
Wintergerst, K. A., Buckingham, B., Gandrud, L., Wong, B. J., Kache, S., & Wilson, D. M. (2006). Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. PEDIATRICS, 118(1), 173–79.

HETEROGENEITY IN THE SPECIFICITY OF THE ISLET CELL CYTOPLASMIC ANTIBODY-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS
KAWAHARA, D. J., Buckingham, B., & Kershnar, A. (1990). HETEROGENEITY IN THE SPECIFICITY OF THE ISLET CELL CYTOPLASMIC ANTIBODY-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS. PANCREAS, 5(6), 647–651.

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1
Sosenko, J. M., Palmer, J. P., Greenbaum, C. J., Mahon, J., Cowie, C., Krischer, J. P., … Skyler, J. S. (2007). Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes - The Diabetes Prevention Trial-Type 1. DIABETES CARE, 30(1), 38–42.

Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm
Wintergerst, K. A., Deiss, D., Buckingham, B., Cantwell, M., Kache, S., Agarwal, S., … Steil, G. (2007). Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. DIABETES TECHNOLOGY & THERAPEUTICS, 9(3), 211–22.

The medtronic MiniMed gold continuous glucose monitoring system: An effective means to discover hypo- and Hyperglycemia in children under 7 years of age
Gandrud, L. M., Xing, D., Kollman, C., Block, J. M., Kunselman, B., Wilson, D. M., & Buckingham, B. A. (2007). The medtronic MiniMed gold continuous glucose monitoring system: An effective means to discover hypo- and Hyperglycemia in children under 7 years of age. DIABETES TECHNOLOGY & THERAPEUTICS, 9(4), 307–16.

Continuous glucose monitoring in children with type 1 diabetes
Anonymous. (2007). Continuous glucose monitoring in children with type 1 diabetes. JOURNAL OF PEDIATRICS, 151(4), 388–393.

Real-time continuous glucose monitoring.
Buckingham, B., Caswell, K., & Wilson, D. M. (2007). Real-time continuous glucose monitoring. Current Opinion in Endocrinology, Diabetes, and Obesity, 14(4), 288–95.

Detection of a Meal Using Continuous Glucose Monitoring implications for an artificial beta-cell
Dassau, E., Bequette, B. W., Buckingham, B. A., & Doyle, F. J. (2008). Detection of a Meal Using Continuous Glucose Monitoring implications for an artificial beta-cell. DIABETES CARE, 31(2), 295–300.

Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)
Buckingham, B., Xing, D., Weinzimer, S., Fiallo-Scharer, R., Kollman, C., Mauras, N., … Beck, R. (2008). Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). PEDIATRIC DIABETES, 9(2), 142–47.

A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION
KAWAHARA, D. J., Everts, M., Buckingham, B., Sandborg, C., & Berman, M. (1991). A NATURALLY-OCCURRING 6-9-KILODALTON INTERLEUKIN-1 (IL-1) INHIBITOR PREVENTS IL-1-MEDIATED ISLET CYTOTOXICITY BUT NOT IL-1-MEDIATED SUPPRESSION OF INSULIN-SECRETION. JOURNAL OF IMMUNOTHERAPY, 10(3), 182–188.

Duration of Nocturnal Hypoglycemia Before Seizures
Buckingham, B., Wilson, D. M., Lecher, T., Hanas, R., Kaiserman, K., & Cameron, F. (2008). Duration of Nocturnal Hypoglycemia Before Seizures. DIABETES CARE, 31(11), 2110–12.

Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM)
Hirsch, I. B., Armstrong, D., Bergenstal, R. M., Buckingham, B., Childs, B. P., Clarke, W. L., … Wolpert, H. (2008). Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM). DIABETES TECHNOLOGY & THERAPEUTICS, 10(4).

Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study
Hirsch, I. B., Abelseth, J., Bode, B. W., Fischer, J. S., Kaufman, F. R., Mastrototaro, J., … Buckingham, B. A. (2008). Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. DIABETES TECHNOLOGY & THERAPEUTICS, 10(5), 377–383.

Continuous glucose monitoring and intensive treatment of type 1 diabetes
Tamborlane, W. V., Beck, R. W., Bode, B. W., Buckingham, B., Chase, H. P., Clemons, R., … Xing, D. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. NEW ENGLAND JOURNAL OF MEDICINE, 359(14), 1464–U65.

RELATIONSHIP BETWEEN THE CONTENT OF LYSYL OXIDASE DEPENDENT CROSS-LINKS IN SKIN COLLAGEN, NONENZYMATIC GLYCOSYLATION, AND LONG-TERM COMPLICATIONS IN TYPE-I DIABETES-MELLITUS
Buckingham, B., & Reiser, K. M. (1990). RELATIONSHIP BETWEEN THE CONTENT OF LYSYL OXIDASE DEPENDENT CROSS-LINKS IN SKIN COLLAGEN, NONENZYMATIC GLYCOSYLATION, AND LONG-TERM COMPLICATIONS IN TYPE-I DIABETES-MELLITUS. JOURNAL OF CLINICAL INVESTIGATION, 86(4), 1046–1054.

Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Cobry, E., Clinton, P., Gage, V., Caswell, K., Kunselman, E., … Chase, H. P. (2009). Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension. DIABETES TECHNOLOGY & THERAPEUTICS, 11(2), 93–97.

Statistical hypoglycemia prediction.
Cameron, F., Niemeyer, G., Gundy-Burlet, K., & Buckingham, B. (2008). Statistical hypoglycemia prediction. Journal of Diabetes Science and Technology, 2(4), 612–21.

Clinical overview of continuous glucose monitoring.
Buckingham, B. (2008). Clinical overview of continuous glucose monitoring. Journal of Diabetes Science and Technology, 2(2), 300–306.

Probabilistic evolving meal detection and estimation of meal total glucose appearance.
Cameron, F., Niemeyer, G., & Buckingham, B. A. (2009). Probabilistic evolving meal detection and estimation of meal total glucose appearance. Journal of Diabetes Science and Technology, 3(5), 1022–30.

Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., Gage, V., … Doyle, F. J. (2010). Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension. DIABETES CARE, 33(5), 1013–17.

Insulin Pumps in Young Children
Fuld, K., Conrad, B., Buckingham, B., & Wilson, D. M. (2010). Insulin Pumps in Young Children. DIABETES TECHNOLOGY & THERAPEUTICS, 12, S67–S71.

Toward Closing the Loop: An Update on Insulin Pumps and Continuous Glucose Monitoring Systems
Aye, T., Block, J., & Buckingham, B. (2010). Toward Closing the Loop: An Update on Insulin Pumps and Continuous Glucose Monitoring Systems. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 39(3), 609-?

Hemoglobin A(1c) and Mean Glucose in Patients With Type 1 Diabetes Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial
Wilson, D. M., Xing, D., Beck, R. W., Block, J., Bode, B., Fox, L. A., … Tamborlane, W. V. (2011). Hemoglobin A(1c) and Mean Glucose in Patients With Type 1 Diabetes Analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. DIABETES CARE, 34(3), 540–44.

Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset
Fiallo-Scharer, R., Cheng, J., Beck, R. W., Buckingham, B. A., Chase, H. P., Kollman, C., … Xing, D. (2011). Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. DIABETES CARE, 34(3), 586–90.

The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring
Beck, R., Steffes, M., Xing, D., Ruedy, K., Mauras, N., Wilson, D. M., & Kollman, C. (2011). The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. PEDIATRIC DIABETES, 12(8), 690–95.

A closed-loop artificial pancreas based on risk management.
Cameron, F., Bequette, B. W., Wilson, D. M., Buckingham, B. A., Lee, H., & Niemeyer, G. (2011). A closed-loop artificial pancreas based on risk management. Journal of Diabetes Science and Technology, 5(2), 368–79.

The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children
Aye, T., Reiss, A. L., Kesler, S., Hoang, S., Drobny, J., Park, Y., … Buckingham, B. A. (2011). The Feasibility of Detecting Neuropsychologic and Neuroanatomic Effects of Type 1 Diabetes in Young Children. DIABETES CARE, 34(7), 1458–62.

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., … Ruedy, K. (2012). Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatric Diabetes, 13(4), 301–307.

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to < 10 Years
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., … Kollman, C. (2012). A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to < 10 Years. DIABETES CARE, 35(2), 204–10.

Use of continuous glucose monitoring in children and adolescents
Phillip, M., Danne, T., Shalitin, S., Buckingham, B., Laffel, L., Tamborlane, W., & Battelino, T. (2012). Use of continuous glucose monitoring in children and adolescents. PEDIATRIC DIABETES, 13(3), 215–228.

Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study
Garg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., … Kaufman, F. R. (2012). Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study. DIABETES TECHNOLOGY & THERAPEUTICS, 14(3), 205–9.

Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual beta-Cell Function
Sherr, J., Tamborlane, W. V., Xing, D., Tsalikian, E., Mauras, N., Buckingham, B., … Ruedy, K. (2012). Achievement of Target A1C Levels With Negligible Hypoglycemia and Low Glucose Variability in Youth With Short-Term Type 1 Diabetes and Residual beta-Cell Function. DIABETES CARE, 35(4), 817–20.

White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study
Aye, T., Barnea-Goraly, N., Ambler, C., Hoang, S., Schleifer, K., Park, Y., … Buckingham, B. A. (2012). White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study. DIABETES CARE, 35(11), 2167–73.

Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.
Cameron, F., Wilson, D. M., Buckingham, B. A., Arzumanyan, H., Clinton, P., Chase, H. P., … Bequette, B. W. (2012). Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm. Journal of Diabetes Science and Technology, 6(5), 1142–1147.

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., … Wesley, D. M. (2013). Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP). DIABETES TECHNOLOGY & THERAPEUTICS, 15(3), 198–211.

THE SURGICAL-MANAGEMENT OF HYPERINSULINISM IN INFANCY DUE TO NESIDIOBLASTOSIS
Warden, M. J., GERMAN, J. C., & Buckingham, B. A. (1988). THE SURGICAL-MANAGEMENT OF HYPERINSULINISM IN INFANCY DUE TO NESIDIOBLASTOSIS. JOURNAL OF PEDIATRIC SURGERY, 23(5), 462–465.

MULTIPARAMETER IMMUNOLOGICAL STUDIES IN PATIENTS WITH NEWLY DIAGNOSED TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS
Gupta, S., Charles, M. A., Waldeck, N., Kershnar, A., & Buckingham, B. (1986). MULTIPARAMETER IMMUNOLOGICAL STUDIES IN PATIENTS WITH NEWLY DIAGNOSED TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS. DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 3(5), 225–229.

NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN HUMAN TYPE-1 DIABETES
Negishi, K., Waldeck, N., Chandy, G., Buckingham, B., Kershnar, A., Fisher, L., … Charles, A. M. (1987). NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN HUMAN TYPE-1 DIABETES. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY, 89(3), 345–353.

PATHOLOGIC AND IMMUNE FACTORS IN THYROID DISEASE
Buckingham, B. A., Costin, G., KOGUT, M. D., Isaacs, H., & Landing, B. H. (1977). PATHOLOGIC AND IMMUNE FACTORS IN THYROID DISEASE. JOURNAL OF PEDIATRICS, 91(5), 728–733.

INTERFERON RESPONSIVENESS OF NATURAL-KILLER CELLS IN TYPE-I HUMAN DIABETES
Negishi, K., Gupta, S., Chandy, K. G., Waldeck, N., Kershnar, A., Buckingham, B., & Charles, M. A. (1988). INTERFERON RESPONSIVENESS OF NATURAL-KILLER CELLS IN TYPE-I HUMAN DIABETES. DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 7(1), 49–52.

NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES
Negishi, K., Waldeck, N., Chandy, G., Buckingham, B., Kershnar, A., Fisher, L., … Charles, M. A. (1986). NATURAL-KILLER-CELL AND ISLET KILLER-CELL ACTIVITIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES. DIABETOLOGIA, 29(6), 352–357.

COMPLEMENT ACTIVATION IN TYPE-1 HUMAN DIABETES
Sundsmo, J. S., PAPIN, R. A., Wood, L., Hirani, S., Waldeck, N., Buckingham, B., … Charles, M. A. (1985). COMPLEMENT ACTIVATION IN TYPE-1 HUMAN DIABETES. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 35(2), 211–225.

SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS
Buckingham, B., PEREJDA, A. J., Sandborg, C., KERSHNAR, A. K., & UITTO, J. (1986). SKIN, JOINT, AND PULMONARY CHANGES IN TYPE-I DIABETES-MELLITUS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 140(5), 420–423.

AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN MAN .15. CELLULAR AND MOLECULAR-BASIS OF DEFICIENT AUTOLOGOUS MIXED LYMPHOCYTE-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS
Chandy, K. G., Charles, A. M., Kershnar, A., Buckingham, B., Waldeck, N., & Gupta, S. (1984). AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN MAN .15. CELLULAR AND MOLECULAR-BASIS OF DEFICIENT AUTOLOGOUS MIXED LYMPHOCYTE-RESPONSE IN INSULIN-DEPENDENT DIABETES-MELLITUS. JOURNAL OF CLINICAL IMMUNOLOGY, 4(6), 424–428.

IMMUNE ISLET KILLING MECHANISMS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES - INVITRO EXPRESSION OF CELLULAR AND ANTIBODY-MEDIATED ISLET CELL CYTO-TOXICITY IN HUMANS
Charles, M. A., Suzuki, M., Waldeck, N., DODSON, L. E., Slater, L., Ong, K., … Golden, M. (1983). IMMUNE ISLET KILLING MECHANISMS ASSOCIATED WITH INSULIN-DEPENDENT DIABETES - INVITRO EXPRESSION OF CELLULAR AND ANTIBODY-MEDIATED ISLET CELL CYTO-TOXICITY IN HUMANS. JOURNAL OF IMMUNOLOGY, 130(3), 1189–1194.

IMMUNOLOGICAL EVENTS IN NEW ONSET DIABETES
CHARLES, M., Suzuki, M., SUNDSMO, J., Waldeck, N., Negishi, K., Slater, L., … Kershnar, A. (1984). IMMUNOLOGICAL EVENTS IN NEW ONSET DIABETES. BIOMEDICA BIOCHIMICA ACTA, 43(5), 615–619.

SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES
Buckingham, B. A., UITTO, J., Sandborg, C., Keens, T., Roe, T., Costin, G., … Castellano, A. (1984). SCLERODERMA-LIKE CHANGES IN INSULIN-DEPENDENT DIABETES-MELLITUS - CLINICAL AND BIOCHEMICAL-STUDIES. DIABETES CARE, 7(2), 163–169.

DEFICIENCY OF MONOCLONAL-ANTIBODY (LEU 7) DEFINED NK-CELLS IN NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS
Chandy, K. G., Charles, M. A., Buckingham, B., Waldeck, N., Kershnar, A., & Gupta, S. (1984). DEFICIENCY OF MONOCLONAL-ANTIBODY (LEU 7) DEFINED NK-CELLS IN NEWLY DIAGNOSED INSULIN-DEPENDENT DIABETES-MELLITUS. IMMUNOLOGY LETTERS, 8(2), 89–91.

RHABDOMYOLYSIS IN DIABETIC-KETOACIDOSIS
Buckingham, B. A., Roe, T. F., & Yoon, J. W. (1981). RHABDOMYOLYSIS IN DIABETIC-KETOACIDOSIS. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 135(4), 352–354.

STUDIES OF IMMUNE-COMPLEX GLOMERULONEPHRITIS MEDIATED BY HUMAN THYROGLOBULIN
Jordan, S. C., Buckingham, B., Sakai, R., & Olson, D. (1981). STUDIES OF IMMUNE-COMPLEX GLOMERULONEPHRITIS MEDIATED BY HUMAN THYROGLOBULIN. NEW ENGLAND JOURNAL OF MEDICINE, 304(20), 1212–1215.

THYROIDECTOMY FOR HYPERTHYRODISM IN CHILDREN
Andrassy, R. J., Buckingham, B. A., & Weitzman, J. J. (1980). THYROIDECTOMY FOR HYPERTHYRODISM IN CHILDREN. JOURNAL OF PEDIATRIC SURGERY, 15(4), 501–504.

HYPERTHYRODISM IN CHILDREN - A RE-EVALUATION OF TREATMENT
Buckingham, B. A., Costin, G., Roe, T. F., Weitzman, J. J., & KOGUT, M. D. (1981). HYPERTHYRODISM IN CHILDREN - A RE-EVALUATION OF TREATMENT. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 135(2), 112–117.

IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA
Sandborg, C. I., Imfeld, K. L., Zaldivar, F., Wang, Z. S., Buckingham, B. A., & Berman, M. A. (1995). IL-4 EXPRESSION IN HUMAN T-CELLS IS SELECTIVELY INHIBITED BY IL-1-ALPHA AND IL-1-BETA. JOURNAL OF IMMUNOLOGY, 155(11), 5206–5212.

T-]A TRANSVERSION 11 BP FROM A SPLICE ACCEPTOR SITE IN THE HUMAN GENE FOR STEROIDOGENIC ACUTE REGULATORY PROTEIN CAUSES CONGENITAL LIPOID ADRENAL-HYPERPLASIA
Tee, M. K., LIN, D., Sugawara, T., HOLT, J. A., Guiguen, Y., Buckingham, B., … Miller, W. L. (1995). T-]A TRANSVERSION 11 BP FROM A SPLICE ACCEPTOR SITE IN THE HUMAN GENE FOR STEROIDOGENIC ACUTE REGULATORY PROTEIN CAUSES CONGENITAL LIPOID ADRENAL-HYPERPLASIA. HUMAN MOLECULAR GENETICS, 4(12), 2299–2305.

Self-care behaviors in insulin-dependent diabetes: Evaluative tools and their associations with glycemic control
Hanson, C. L., DEGUIRE, M. J., SCHINKEL, A. M., Kolterman, O. G., Goodman, J. P., & Buckingham, B. A. (1996). Self-care behaviors in insulin-dependent diabetes: Evaluative tools and their associations with glycemic control. JOURNAL OF PEDIATRIC PSYCHOLOGY, 21(4), 467–482.

SURGICAL TREATMENT OF HYPERTHYROIDISM IN CHILDREN
Wesley, J. R., Buckingham, B. A., GAHR, J. A., Isaacs, H., KOGUT, M. D., & Weitzman, J. J. (1977). SURGICAL TREATMENT OF HYPERTHYROIDISM IN CHILDREN. SURGERY GYNECOLOGY & OBSTETRICS, 145(3), 343–346.

Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus
Berman, M. A., Sandborg, C. I., Wang, Z. S., Imfeld, K. L., Zaldivar, F., Dadufalza, V., & Buckingham, B. A. (1996). Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. JOURNAL OF IMMUNOLOGY, 157(10), 4690–4696.

THYROID-FUNCTION IN CHILDREN WITH CHRONIC RENAL-FAILURE
Wassner, S. J., Buckingham, B. A., KERSHNAR, A. J., MALEKZADEH, M. H., Pennisi, A. J., & Fine, R. N. (1977). THYROID-FUNCTION IN CHILDREN WITH CHRONIC RENAL-FAILURE. NEPHRON, 19(4), 236–241.

Insulin infusion set survival comparing Novolog with Humalog
Buckingham, B., Block, J., Clinton, P., Kunselman, E., & Wilson, D. (2005). Insulin infusion set survival comparing Novolog with Humalog. Presented at the 41st Annual Meeting of the European-Association-for-the-Study-of-Diabetes, ATHENS,GREECE,GREECE,GREECE: SPRINGER.

RANDOMIZED TRIAL OF REMOTE NOCTURNAL CONTINUOUS GLUCOSE MONITORING AT DIABETES CAMPS USING THE DEXCOM G4 PLATINUM AND DIAS
Buckingham, B., Keith-Hynes, P., PEYSER, T., DeSalvo, D., Caswell, K., Ferrari, G., … Kovatchev, B. (2013). RANDOMIZED TRIAL OF REMOTE NOCTURNAL CONTINUOUS GLUCOSE MONITORING AT DIABETES CAMPS USING THE DEXCOM G4 PLATINUM AND DIAS. MARY ANN LIEBERT INC.

DOES INTENSIVE METABOLIC CONTROL AT THE ONSET OF DIABETES FOLLOWED BY ONE YEAR OF SENSOR AUGMENTED PUMP THERAPY IMPROVE C-PEPTIDE LEVELS ONE YEAR POST DIAGNOSIS?
Buckingham, B., Ruedy, K., Chase, H. P., Weinzimer, S., DiMeglio, L., Russell, W., … Beck, R. (2013). DOES INTENSIVE METABOLIC CONTROL AT THE ONSET OF DIABETES FOLLOWED BY ONE YEAR OF SENSOR AUGMENTED PUMP THERAPY IMPROVE C-PEPTIDE LEVELS ONE YEAR POST DIAGNOSIS? MARY ANN LIEBERT INC.

BENEFITS OF ACCELEROMETER AND HEART RATE DATA FOR HYPOGLYCEMIA MITIGATION
Cameron, F., Stenerson, M., Wilson, D. M., Maahs, D. M., Mayer-Davis, E. J., Bequette, B. W., & Buckingham, B. A. (2013). BENEFITS OF ACCELEROMETER AND HEART RATE DATA FOR HYPOGLYCEMIA MITIGATION. MARY ANN LIEBERT INC.

USING ACTIVITY MONITORS TO IMPROVE CGM SENSOR ANOMALY DETECTION
BAYSAL, N., Cameron, F., Stenerson, M., Buckingham, B. A., Wilson, D. M., Mayer-Davis, E. J., … Bequette, B. W. (2013). USING ACTIVITY MONITORS TO IMPROVE CGM SENSOR ANOMALY DETECTION. MARY ANN LIEBERT INC.

The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes Diagnosis
Buckingham, B. A., Beck, R. W., Ruedy, K. J., Cheng, P., Kollman, C., Weinzimer, S. A., … Sosenko, J. M. (2013). The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes Diagnosis. DIABETES TECHNOLOGY & THERAPEUTICS, 15(5), 401–8.

Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring A safety net for the artificial pancreas
Dassau, E., Cameron, F., Lee, H., Bequette, B. W., Zisser, H., Jovanovic, L., … Doyle, F. J. (2010). Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring A safety net for the artificial pancreas. DIABETES CARE, 33(6), 1249–54.

Validation of Measures of Satisfaction with and Impact of Continuous and Conventional Glucose Monitoring
Hirsch, I. B., Gilliam, L. K., Fitzpatrick, K., Khakpour, D., Weinzimer, S. A., Tamborlane, W. V., … Cheng, J. (2010). Validation of Measures of Satisfaction with and Impact of Continuous and Conventional Glucose Monitoring. DIABETES TECHNOLOGY & THERAPEUTICS, 12(9), 679–84.

Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
Xing, D., Kollman, C., Beck, R. W., Tamborlane, W. V., Laffel, L., Buckingham, B. A., … Ruedy, K. J. (2011). Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring. DIABETES TECHNOLOGY & THERAPEUTICS, 13(3), 351–58.

RACE AND SOCIOECONOMIC STATUS ARE ASSOCIATED WITH INSULIN PUMP THERAPY IN YOUTH IN THE FIRST YEAR FOLLOWING DIAGNOSIS OF TYPE 1 DIABETES
Wood, J., Lin, M., Connor, C., Ruedy, K., Beck, R., KOLLMAN, C., … Tamborlane, W. (2013). RACE AND SOCIOECONOMIC STATUS ARE ASSOCIATED WITH INSULIN PUMP THERAPY IN YOUTH IN THE FIRST YEAR FOLLOWING DIAGNOSIS OF TYPE 1 DIABETES. MARY ANN LIEBERT INC.

JOINT AND PULMONARY CHANGES IN DIABETES - REPLY
Buckingham, B., Kershnar, A., Anas, N., Sandborg, C., & UITTO, J. (1987). JOINT AND PULMONARY CHANGES IN DIABETES - REPLY. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 141(3), 245–245.

Use of continuous glucose monitoring with a proportional- integral-derivative algorithm to achieve tight glucose control in the pediatric intensive care unit
Fuld, K. B., Pageler, N., Cortez, B., Cache, S., & Buckingham, B. (2009). Use of continuous glucose monitoring with a proportional- integral-derivative algorithm to achieve tight glucose control in the pediatric intensive care unit. KARGER.

Blunted Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents With Well-Controlled Type 1 Diabetes
Tsalikian, E., Tamborlane, W., Xing, D., Becker, D. M., Mauras, N., Fiallo-Scharer, R., … Kollman, C. (2009). Blunted Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents With Well-Controlled Type 1 Diabetes. DIABETES CARE, 32(11), 1954–1959.

Infantile hypercalcemia associated with Williams Syndrome treated successfully with bisphosphonate.
Cagle, A. P., Waguespack, S. G., Buckingham, B. A., Shankar, R., & DiMeglio, L. A. (2003). Infantile hypercalcemia associated with Williams Syndrome treated successfully with bisphosphonate. Presented at the 25th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, MINNEAPOLIS,MN: WILEY-BLACKWELL.

Outpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal Hypoglycemia
Buckingham, B. A., Cameron, F., Calhoun, P., Maahs, D. M., Wilson, D. M., Chase, H. P., … Kollman, C. (2013). Outpatient Safety Assessment of an In-Home Predictive Low-Glucose Suspend System with Type 1 Diabetes Subjects at Elevated Risk of Nocturnal Hypoglycemia. DIABETES TECHNOLOGY & THERAPEUTICS, 15(8), 622–27.

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes
Sherr, J., Xing, D., Ruedy, K. J., Beck, R. W., Kollman, C., Buckingham, B., … Tamborlane, W. V. (2013). Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes. DIABETES CARE, 36(6), 1470–76.

Continuous glucose monitoring: current use and future directions.
DeSalvo, D., & Buckingham, B. (2013). Continuous glucose monitoring: current use and future directions. Current Diabetes Reports, 13(5), 657–662.

Alterations in white matter structure in young children with type 1 diabetes mellitus
Barnea-Goraly, N., Raman, M., Mazaika, P., & Marzelli, M. (2014). Alterations in white matter structure in young children with type 1 diabetes mellitus. DIABETES CARE, 332–40.

Race, Socioeconomic Status, and Treatment Center Are Associated with Insulin Pump Therapy in Youth in the First Year Following Diagnosis of Type 1 Diabetes
Lin, M. H., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Buckingham, B., … Wood, J. R. (2013). Race, Socioeconomic Status, and Treatment Center Are Associated with Insulin Pump Therapy in Youth in the First Year Following Diagnosis of Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 15(11), 929–34.

Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes.
Marzelli, M. J., Mazaika, P. K., Barnea-Goraly, N., Hershey, T., Tsalikian, E., Tamborlane, W., … Reiss, A. L. (2014). Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes, 63(1), 343–53.

Relative accuracy of the BD Logic (R) and FreeStyle (R) blood glucose meters
Fox, L. A., Beck, R., Steffes, M., Chase, P., Coffey, J., Wysocki, T., … Ruedy, K. (2007). Relative accuracy of the BD Logic (R) and FreeStyle (R) blood glucose meters. DIABETES TECHNOLOGY & THERAPEUTICS, 9(2), 165–68.

Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N., Beck, R., … Ruedy, K. (2012). Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. PEDIATRIC DIABETES, 13(4), 294–300.

The Pediatric Diabetes Consortium: Improving Care of Children with Type 1 Diabetes Through Collaborative Research
Beck, R., Klingensmith, G., Haymond, M., Wood, J., Buckingham, B., Schatz, D., … Tamborlane, W. (2010). The Pediatric Diabetes Consortium: Improving Care of Children with Type 1 Diabetes Through Collaborative Research. DIABETES TECHNOLOGY & THERAPEUTICS, 12(9), 685–88.

In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus.
Patek, S. D., Bequette, B. W., Breton, M., Buckingham, B. A., Dassau, E., Doyle, F. J., … Zisser, H. (2009). In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. Journal of Diabetes Science and Technology, 3(2), 269–282.

The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis.
Buckingham, B. A., Beck, R. W., Ruedy, K. J., Cheng, P., Kollman, C., Weinzimer, S. A., … Cantwell, M. (2013). The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis. Diabetes Technology & Therapeutics, 15(5), 401–408.

Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes
Beck, R. W., Buckingham, B., Miller, K., Wolpert, H., Xing, D., Block, J. M., … Tamborlane, W. V. (2009). Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes. DIABETES CARE, 32(11), 1947–1953.

The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
Beck, R. W., Hirsch, I. B., Laffel, L., Tamborlane, W. V., Bode, B. W., Buckingham, B., … Xing, D. (2009). The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 32(8), 1378–1383.

Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011). Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 96(10), 2968–2979.

Outcome measures for outpatient hypoglycemia prevention studies.
Beck, R. W., Kollman, C., Xing, D., Buckingham, B. A., & Chase, H. P. (2011). Outcome measures for outpatient hypoglycemia prevention studies. Journal of Diabetes Science and Technology, 5(4), 999–1004.

In Silico Evaluation Platform for Artificial Pancreatic beta-Cell Development-A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop
Dassau, E., Palerm, C. C., Zisser, H., Buckingham, B. A., Jovanovic, L., & Doyle, F. J. (2009). In Silico Evaluation Platform for Artificial Pancreatic beta-Cell Development-A Dynamic Simulator for Closed-Loop Control with Hardware-in-the-Loop. DIABETES TECHNOLOGY & THERAPEUTICS, 11(3), 187–194.

Alterations in white matter structure in young children with type 1 diabetes.
Barnea-Goraly, N., Raman, M., Mazaika, P., Marzelli, M., Hershey, T., Weinzimer, S. A., … Reiss, A. L. (2014). Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care, 37(2), 332–340.

Diabetes Technology and the Human Factor
Liberman, A., Buckingham, B., & Phillip, M. (2013). Diabetes Technology and the Human Factor. DIABETES TECHNOLOGY & THERAPEUTICS, 15, S117–S125.

The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
Brazg, R. L., Bailey, T. S., Garg, S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., … Lee, S. W. (2011). The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. Journal of Diabetes Science and Technology, 5(6), 1466–1471.

Diabetes technology and the human factor
Liberman, A., Buckingham, B., & Phillip, M. (2011). Diabetes technology and the human factor. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 65, 83–90.

Metabolic tests to determine risk for type 1 diabetes in clinical trials
Greenbaum, C. J., Buckingham, B., Chase, H. P., & Krischer, J. (2011). Metabolic tests to determine risk for type 1 diabetes in clinical trials. DIABETES-METABOLISM RESEARCH AND REVIEWS, 27(6), 584–589.

Effectiveness of Early Intensive Therapy on beta-Cell Preservation in Type 1 Diabetes
Buckingham, B., Beck, R. W., Ruedy, K. J., Cheng, P., Kollman, C., Weinzimer, S. A., … Tamborlane, W. V. (2013). Effectiveness of Early Intensive Therapy on beta-Cell Preservation in Type 1 Diabetes. DIABETES CARE, 36(12), 4030–35.

A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.
Lee, H., Buckingham, B. A., Wilson, D. M., & Bequette, B. W. (2009). A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator. Journal of Diabetes Science and Technology, 3(5), 1082–1090.

Acceptability and utility of the mySentry remote glucose monitoring system.
Kaiserman, K., Buckingham, B. A., Prakasam, G., Gunville, F., Slover, R. H., Wang, Y., … Welsh, J. B. (2013). Acceptability and utility of the mySentry remote glucose monitoring system. Journal of Diabetes Science and Technology, 7(2), 356–361.

Diabetes technology and the human factor.
Liberman, A., Buckingham, B., & Phillip, M. (2014). Diabetes technology and the human factor. Diabetes Technology & Therapeutics, 16, S110–8.

Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia
DeSalvo, D. J., Keith-Hynes, P., Peyser, T., Place, J., Caswell, K., Wilson, D. M., … Buckingham, B. A. (2014). Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia. DIABETES TECHNOLOGY & THERAPEUTICS, 16(1), 1–7.

Cognitive functioning in young children with type 1 diabetes.
Cato, M. A., Mauras, N., Ambrosino, J., Bondurant, A., Conrad, A. L., Kollman, C., … Hershey, T. (2014). Cognitive functioning in young children with type 1 diabetes. Journal of the International Neuropsychological Society , 20(2), 238–47.

Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study.
Garg, S. K., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., … Kaufman, F. R. (2014). Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study. Diabetes Technology & Therapeutics, 16(3), 125–30.

Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus
Arbelaez, A. M., Xing, D., Cryer, P. E., Kollman, C., Beck, R. W., Sherr, J., … White, N. H. (2014). Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. PEDIATRIC DIABETES, 15(2), 127–34.

Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis.
Sherr, J., Tsalikian, E., Fox, L., Buckingham, B., Weinzimer, S., Tamborlane, W. V., … Beck, R. W. (2014). Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis. Diabetes Care, 37(6), 1741–44.

Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes cAMP.
Ly, T. T., Breton, M. D., Keith-Hynes, P., De Salvo, D., Clinton, P., Benassi, K., … Buckingham, B. A. (2014). Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes cAMP. Diabetes Care, 37(8), 2310–16.

Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control.
DeSalvo, D. J., Shanmugham, S., Ly, T. T., Wilson, D. M., & Buckingham, B. A. (2014). Accuracy evaluation of blood glucose monitoring systems in children on overnight closed-loop control. Journal of Diabetes Science and Technology, 8(5), 969–73.

A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes
Maahs, D. M., Calhoun, P., Buckingham, B. A., Chase, H. P., Hramiak, I., Lum, J., … Beck, R. W. (2014). A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes. DIABETES CARE, 37(7), 1885–91.

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.
Maahs, D. M., Calhoun, P., Buckingham, B. A., Chase, H. P., Hramiak, I., Lum, J., … Beck, R. W. (2014). A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care, 37(7), 1885–91.

Detecting Sensor and Insulin Infusion Set Anomalies in an Artificial Pancreas
Baysal, N., Cameron, F., Buckingham, B. A., Wilson, D. M., & Bequette, B. W. (2013). Detecting Sensor and Insulin Infusion Set Anomalies in an Artificial Pancreas. Presented at the American Control Conference (ACC), WASHINGTON,DC,DC,DC: IEEE.

Randomized Trial of Infusion Set Function: Steel Versus Teflon
Patel, P. J., Benasi, K., Ferrari, G., Evans, M. G., Shanmugham, S., Wilson, D. M., & Buckingham, B. A. (2014). Randomized Trial of Infusion Set Function: Steel Versus Teflon. DIABETES TECHNOLOGY & THERAPEUTICS, 16(1), 15–19.

Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals
Cameron, F., Niemeyer, G., Wilson, D. M., Bequette, B. W., Benassi, K. S., Clinton, P., & Buckingham, B. A. (2014). Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals. DIABETES TECHNOLOGY & THERAPEUTICS, 16(11), 728–34.

Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery with Type 1 Diabetes
Chase, H. P., Doyle, F. J., Zisser, H., Renard, E., Nimri, R., Cobelli, C., … Beck, R. W. (2014). Multicenter Closed-Loop/Hybrid Meal Bolus Insulin Delivery with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 16(10), 623–32.

Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis
Redondo, M. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Wood, J. R., … Tamborlane, W. V. (2014). Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. PEDIATRIC DIABETES, 15(4), 294–302.

Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites
Zisser, H., Renard, E., Kovatchev, B., Cobelli, C., Avogaro, A., Nimri, R., … Beck, R. W. (2014). Multicenter Closed-Loop Insulin Delivery Study Points to Challenges for Keeping Blood Glucose in a Safe Range by a Control Algorithm in Adults and Adolescents with Type 1 Diabetes from Various Sites. DIABETES TECHNOLOGY & THERAPEUTICS, 16(10), 613–22.

Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System
Beck, R. W., Raghinaru, D., Wadwa, R. P., Chase, H. P., Maahs, D. M., & Buckingham, B. A. (2014). Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System. DIABETES CARE, 37(5), 1224–1229.

Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes
Dimeglio, L. A., Cheng, P., Beck, R. W., Kollman, C., Ruedy, K. J., Slover, R., … Buckingham, B. (2016). Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes. PEDIATRIC DIABETES, 17(4), 237–43.

Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia
Mauras, N., Mazaika, P., Buckingham, B., Weinzimer, S., White, N. H., Tsalikian, E., … Reiss, A. L. (2015). Longitudinal Assessment of Neuroanatomical and Cognitive Differences in Young Children With Type 1 Diabetes: Association With Hyperglycemia. DIABETES, 64(5), 1770–79.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis
Buckingham, B. A., Raghinaru, D., Cameron, F., Bequette, B. W., Chase, H. P., Maahs, D. M., … Beck, R. W. (2015). Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. DIABETES CARE, 38(7), 1197–1204.

Factors Associated with Nocturnal Hypoglycemia in At-Risk Adolescents and Young Adults with Type 1 Diabetes
Wilson, D. M., Calhoun, P. M., Maahs, D. M., Chase, H. P., Messer, L., Buckingham, B. A., … Beck, R. W. (2015). Factors Associated with Nocturnal Hypoglycemia in At-Risk Adolescents and Young Adults with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 17(6), 385–91.

Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp
Ly, T. T., Roy, A., Grosman, B., Shin, J., Campbell, A., Monirabbasi, S., … Buckingham, B. A. (2015). Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp. DIABETES CARE, 38(7), 1205–11.

CGM-measured glucose values have a strong correlation with C-peptide, HbA(1c) and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes
Buckingham, B., Cheng, P., Beck, R. W., Kollman, C., Ruedy, K. J., Weinzimer, S. A., … Tamborlane, W. (2015). CGM-measured glucose values have a strong correlation with C-peptide, HbA(1c) and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes. DIABETOLOGIA, 58(6), 1167–74.

Body Mass Index Changes in Youth in the First Year after Type 1 Diabetes Diagnosis
Gregg, B., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Schatz, D., … Lee, J. M. (2015). Body Mass Index Changes in Youth in the First Year after Type 1 Diabetes Diagnosis. JOURNAL OF PEDIATRICS, 166(5), 1265–U494.

DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials.
Place, J., Robert, A., Ben Brahim, N., Keith-Hynes, P., Farret, A., Pelletier, M.-J., … Renard, E. (2013). DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. Journal of Diabetes Science and Technology, 7(6), 1427–1435.

Diabetes technology and the human factor.
Liberman, A., Buckingham, B., & Phillip, M. (2012). Diabetes technology and the human factor. International Journal of Clinical Practice. Supplement, (175), 79–84.

Diabetes technology and the human factor.
Liberman, A., Phillip, M., & Buckingham, B. (2015). Diabetes technology and the human factor. Diabetes Technology & Therapeutics, 17, S109–18.

A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas.
Baysal, N., Cameron, F., Buckingham, B. A., Wilson, D. M., Chase, H. P., Maahs, D. M., & Bequette, B. W. (2014). A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas. Journal of Diabetes Science and Technology, 8(6), 1091–96.

The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.
Stenerson, M., Cameron, F., Payne, S. R., Payne, S. L., Ly, T. T., Wilson, D. M., & Buckingham, B. A. (2015). The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes. Journal of Diabetes Science and Technology, 9(1), 80–85.

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197-1204.
Buckingham, B. A., Raghinaru, D., Cameron, F., Bequette, B. W., Chase, H. P., Maahs, D. M., … Beck, R. W. (2015). Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197-1204. Diabetes Care, 38(9), 1813-?

Diabetes Technology and the Human Factor
Liberman, A., Phillip, M., & Buckingham, B. (2015). Diabetes Technology and the Human Factor. DIABETES TECHNOLOGY & THERAPEUTICS, 17, S109–S118.

Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.
Mazaika, P. K., Weinzimer, S. A., Mauras, N., Buckingham, B., White, N. H., Tsalikian, E., … Reiss, A. L. (2016). Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes, 65(2), 476–85.

Diabetes Technology and the Human Factor
Liberman, A., & Buckingham, B. (2016). Diabetes Technology and the Human Factor. DIABETES TECHNOLOGY & THERAPEUTICS, 18, S101–S111.

Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas
Forlenza, G. P., Buckingham, B., & Maahs, D. M. (2016). Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas. JOURNAL OF PEDIATRICS, 169, 13–20.

Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months.
Cato, M. A., Mauras, N., Mazaika, P., Kollman, C., Cheng, P., Aye, T., … Hershey, T. (2016). Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months. Journal of the International Neuropsychological Society , 22(3), 293–302.

Closed-loop control in type 1 diabetes.
Buckingham, B., & Ly, T. (2016). Closed-loop control in type 1 diabetes. The Lancet. Diabetes & Endocrinology, 4(3), 191–93.

Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control.
Floyd, B. D., Block, J. M., Buckingham, B. B., Ly, T., Foster, N., Wright, R., … Shah, A. C. (2016). Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control. Pediatric Diabetes.

Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes.
Hosseini, S. M. H., Mazaika, P., Mauras, N., Buckingham, B., Weinzimer, S. A., Tsalikian, E., … Reiss, A. L. (2016). Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes. Human Brain Mapping, 37(11), 4034–46.

Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp
Ly, T. T., Keenan, D. B., Roy, A., Han, J., Grosman, B., Cantwell, M., … Buckingham, B. A. (2016). Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp. DIABETES TECHNOLOGY & THERAPEUTICS, 18(6), 377–84.

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., … Lum, J. W. (2016). Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report. Diabetes Care, 39(7), 1175–79.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.
Anderson, S. M., Raghinaru, D., Pinsker, J. E., Boscari, F., Renard, E., Buckingham, B. A., … Kovatchev, B. (2016). Multinational Home Use of Closed-Loop Control Is Safe and Effective. Diabetes Care, 39(7), 1143–50.

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes
Karlin, A. W., Ly, T. T., Pyle, L., Forlenza, G. P., Messer, L., Wadwa, R. P., … Buckingham, B. (2016). Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 18(7), 429–35.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis (vol 38, pg 1197, 2015)
Buckingham, B. A., Raghinaru, D., Cameron, F., Bequette, B. W., Chase, H. P., Maahs, D. M., … Beck, R. W. (2015). Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis (vol 38, pg 1197, 2015). DIABETES CARE, 38(9), 1813–13.

Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.
Evert, A. B., Bode, B. W., Buckingham, B. A., Nardacci, E., Verderese, C. A., Wolff-McDonagh, P., … Hirsch, I. B. (2016). Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions. Diabetes Educator, 42(4), 470–84.

Cognitive and behavioral characteristics of Turner syndrome: Exploring hormones in female sexual a role for ovarian differentiation
Collaer, M. L., Geffner, M. E., Kaufman, F. R., Buckingham, B., & Hines, M. (2002). Cognitive and behavioral characteristics of Turner syndrome: Exploring hormones in female sexual a role for ovarian differentiation. HORMONES AND BEHAVIOR, 41(2), 139–55.

In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.
Messer, L. H., Calhoun, P., Buckingham, B., Wilson, D. M., Hramiak, I., Ly, T. T., … Maahs, D. M. (2016). In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes. Pediatric Diabetes, -?

Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose?
Steil, G. M., Deiss, D., Shih, J., Buckingham, B., Weinzimer, S., & Agus, M. S. D. (2009). Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose? Journal of Diabetes Science and Technology, 3(1), 125–140.

Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes.
Calhoun, P. M., Buckingham, B. A., Maahs, D. M., Hramiak, I., Wilson, D. M., Aye, T., … Lum, J. (2016). Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes. Journal of Diabetes Science and Technology, 10(6), 1216–21.

Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
Cescon, M., DeSalvo, D. J., Ly, T. T., Maahs, D. M., Messer, L. H., Buckingham, B. A., … Dassau, E. (2016). Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. Journal of Diabetes Science and Technology, 10(6), 1268–76.

Compensatory Hyper-Connectivity in Developing Brains of Young Children with Type 1 Diabetes.
Saggar, M., Tsalikian, E., Mauras, N., Mazaika, P., White, N. H., Weinzimer, S., … Reiss, A. L. (2016). Compensatory Hyper-Connectivity in Developing Brains of Young Children with Type 1 Diabetes. Diabetes.

The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes.
Stenerson, M., Cameron, F., Wilson, D. M., Harris, B., Payne, S., Bequette, B. W., & Buckingham, B. A. (2014). The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes. Journal of Diabetes Science and Technology, 8(1), 64–69.

Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.
Wadwa, R. P., Chase, H. P., Raghinaru, D., Buckingham, B. A., Hramiak, I., Maahs, D. M., … Lum, J. (2016). Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension. Pediatric Diabetes.

Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry.
Fox, L. A., Mubasher, M., Wolfsdorf, J. I., Buckingham, B. A., Peters, A. L., Tamborlane, W. V., … Beck, R. W. (2016). Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry. Journal of Diabetes, 8(6), 834–38.

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)
Howsmon, D. P., Cameron, F., Baysal, N., Ly, T. T., Forlenza, G. P., Maahs, D. M., … Bequette, B. W. (2017). Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs). SENSORS, 17(1).

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
El-Khatib, F. H., Balliro, C., Hillard, M. A., Magyar, K. L., Ekhlaspour, L., Sinha, M., … Russell, S. J. (2017). Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. LANCET, 389(10067), 369–80.

Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
Ly, T. T., Weinzimer, S. A., Maahs, D. M., Sherr, J. L., Roy, A., Grosman, B., … Buckingham, B. A. (2016). Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance. Pediatric Diabetes.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery
Kovatchev, B., Cheng, P., Anderson, S. M., Pinsker, J. E., Boscari, F., Buckingham, B. A., … Beck, R. W. (2017). Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery. DIABETES TECHNOLOGY & THERAPEUTICS, 19(1), 18-?

Evaluation of a Predictive Low-Glucose Management System In-Clinic.
Buckingham, B. A., Bailey, T. S., Christiansen, M., Garg, S., Weinzimer, S., Bode, B., … Kaufman, F. R. (2017). Evaluation of a Predictive Low-Glucose Management System In-Clinic. Diabetes Technology & Therapeutics.

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., … Kaufman, F. R. (2017). Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics.

Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
Spaic, T., Driscoll, M., Raghinaru, D., Buckingham, B. A., Wilson, D. M., Clinton, P., … Ly, T. T. (2017). Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes. Diabetes Care, 40(3), 359–66.

Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System
Iturralde, E., Tanenbaum, M. L., Hanes, S. J., Suttiratana, S. C., Ambrosino, J. M., Ly, T. T., … Hood, K. K. (2017). Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. DIABETES EDUCATOR, 43(2), 223–32.

Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.
Forlenza, G. P., Deshpande, S., Ly, T. T., Howsmon, D. P., Cameron, F., Baysal, N., … Dassau, E. (2017). Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care.

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.
Huyett, L. M., Ly, T. T., Forlenza, G. P., Reuschel-DiVirgilio, S., Messer, L. H., Wadwa, R. P., … Dassau, E. (2017). Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. Diabetes Technology & Therapeutics.

Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control
Floyd, B. D., Block, J. M., Buckingham, B. B., Ly, T., Foster, N., Wright, R., … Shah, A. C. (2017). Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control. PEDIATRIC DIABETES, 18(3), 204–12.

Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes
Saggar, M., Tsalikian, E., Mauras, N., Mazaika, P., White, N. H., Weinzimer, S., … Reiss, A. L. (2017). Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes. DIABETES, 66(3), 754–62.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.
Messer, L. H., Forlenza, G. P., Sherr, J. L., Wadwa, R. P., Buckingham, B. A., Weinzimer, S. A., … Slover, R. H. (2018). Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System. Diabetes Care, 41(4), 789–96.

International Consensus on Use of Continuous Glucose Monitoring.
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., … Phillip, M. (2017). International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care, 40(12), 1631–40.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
Cameron, F. M., Ly, T. T., Buckingham, B. A., Maahs, D. M., Forlenza, G. P., Levy, C. J., … Bequette, B. W. (2017). Closed-Loop Control Without Meal Announcement in Type 1 Diabetes. Diabetes Technology & Therapeutics, 19(9), 527–32.

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users.
Tanenbaum, M. L., Iturralde, E., Hanes, S. J., Suttiratana, S. C., Ambrosino, J. M., Ly, T. T., … Hood, K. K. (2017). Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users. Journal of Health Psychology, 1359105317718615.

HUMAN FACTORS DURING TRIAL OF A HYBRID CLOSED LOOP SYSTEM FOR TYPE 1 DIABETES MANAGEMENT
Adams, R. N., Tanenbaum, M. L., Hanes, S. J., Ambrosino, J. M., Ly, T. T., Maahs, D. M., … Hood, K. K. (2018). HUMAN FACTORS DURING TRIAL OF A HYBRID CLOSED LOOP SYSTEM FOR TYPE 1 DIABETES MANAGEMENT. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

GLUCOSE CONTROL IN ADOLESCENTS WITH T1D DURING THE MEDTRONIC HYBRID CLOSED-LOOP PIVOTAL TRIAL
Sherr, J., Weinzimer, S. A., Slover, R. H., Buckingham, B. A., Criego, A. B., Anderson, S. M., … Kaufman, F. R. (2017). GLUCOSE CONTROL IN ADOLESCENTS WITH T1D DURING THE MEDTRONIC HYBRID CLOSED-LOOP PIVOTAL TRIAL. HORMONE RESEARCH IN PAEDIATRICS. KARGER.

Pivotal Trial of a Hybrid-Closed Loop System in Type 1 Dabetes
Burkett, L., Lee, S. W., Shin, J., Kaufman, F. R., Buckingham, B. A., Slover, R., & Weinzimer, S. (2017). Pivotal Trial of a Hybrid-Closed Loop System in Type 1 Dabetes. JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES. ELSEVIER SCIENCE INC.

Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study
Calles-Escandon, J., Koch, K. L., Hasler, W. L., Van Natta, M. L., Pasricha, P. J., Tonascia, J., … Farrugia, G. (2018). Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. PLOS ONE, 13(4), e0194759.

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents
Forlenza, G. P., Raghinaru, D., Cameron, F., Bequette, B. W., Chase, H. P., Wadwa, R. P., … Buckingham, B. A. (2018). Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents. PEDIATRIC DIABETES, 19(3), 420–28.

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes
Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., … Harris, D. R. (2017). A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. JOURNAL OF THE ENDOCRINE SOCIETY, 1(12), 1461–76.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data
Garcia, A., Balo, A. K., Buckingham, B. A., Hirsch, I. B., & Peyser, T. A. (2017). Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data. DIABETES TECHNOLOGY & THERAPEUTICS, 19(12), 699–706.

Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm
Buckingham, B. A., Forlenza, G. P., Pinsker, J. E., Christiansen, M. P., Wadwa, R. P., Schneider, J., … Ly, T. T. (2018). Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm. DIABETES TECHNOLOGY & THERAPEUTICS, 20(4), 257–62.

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
Peyser, T. A., Balo, A. K., Buckingham, B. A., Hirsch, I. B., & Garcia, A. (2018). Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data. DIABETES TECHNOLOGY & THERAPEUTICS, 20(1), 6–16.

Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
Alexander, C. M., Amiel, S., Beck, R., Bergenstal, R. M., Bloomgarden, Z., Brown, A., … Wood, R. (2018). Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics. DIABETES CARE, 41(6), E92–E94.

Measures from Nonlinear Dynamics Reflect Glucose Current Sensor Degradation
Mauritzen, E., Mandell, A., Tallman, D., & Buckingham, B. (2017). Measures from Nonlinear Dynamics Reflect Glucose Current Sensor Degradation. PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON APPLICATIONS IN NONLINEAR DYNAMICS (ICAND 2016), 6, 189–93.

Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting
Forlenza, G. P., Cameron, F. M., Ly, T. T., Lam, D., Howsmon, D. P., Baysal, N., … Buckingham, B. A. (2018). Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting. DIABETES TECHNOLOGY & THERAPEUTICS, 20(5), 335–43.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration
Messer, L. H., Forlenza, G. P., Wadwa, R. P., Weinzimer, S. A., Sherr, J. L., Hood, K. K., … Maahs, D. M. (2018). The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration. PEDIATRIC DIABETES, 19(1), 14–17.

Overnight Hypoglycemia and Hyperglycemia Mitigation for Individuals with Type 1 Diabetes HOW RISKS CAN BE REDUCED
Bequette, B. W., Cameron, F., Buckingham, B. A., Maahs, D. M., & Lum, J. (2018). Overnight Hypoglycemia and Hyperglycemia Mitigation for Individuals with Type 1 Diabetes HOW RISKS CAN BE REDUCED. IEEE CONTROL SYSTEMS MAGAZINE, 38(1), 125–34.

Persistence of abnormalities in white matter in children with type 1 diabetes
Fox, L. A., Hershey, T., Mauras, N., Arbelaez, A. M., Tamborlane, W. V., Buckingham, B., … Mazaika, P. (2018). Persistence of abnormalities in white matter in children with type 1 diabetes. DIABETOLOGIA, 61(7), 1538–47.

Advances in Care for Insulin-Requiring Patients Without Closed Loop.
Lal, R. A., Buckingham, B., & Maahs, D. M. (2018). Advances in Care for Insulin-Requiring Patients Without Closed Loop. Diabetes Technology & Therapeutics, 20(S2), S285–S291.

Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes.
Mazaika, P. K., Aye, T., Reiss, A. L., & Buckingham, B. A. (2018). Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes. Diabetes Care, 41(7), 1535–37.

Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All.
Prahalad, P., Addala, A., Buckingham, B., Wilson, D. M., & Maahs, D. M. (2018). Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All. Diabetes Technology & Therapeutics.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
Buckingham, B. A., Christiansen, M. P., Forlenza, G. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., … Ly, T. T. (2018). Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
Adams, R. N., Tanenbaum, M. L., Hanes, S. J., Ambrosino, J. M., Ly, T. T., Maahs, D. M., … Hood, K. K. (2018). Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management. Diabetes Technology & Therapeutics.

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., … Beck, R. W. (2018). Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. DIABETES CARE, 41(10), 2155–61.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes
Danne, T., Phillip, M., Buckingham, B. A., Jarosz-Chobot, P., Saboo, B., Urakami, T., … Codner, E. (2018). ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. PEDIATRIC DIABETES, 19, 115–35.

In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes
Wood, M. A., Shulman, D. I., Forlenza, G. P., Bode, B. W., Pinhas-Hamiel, O., Buckingham, B. A., … Kaufman, F. R. (2018). In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS.

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
Forlenza, G. P., Pinhas-Hamiel, O., Liljenquist, D. R., Shulman, D. I., Bailey, T. S., Bode, B. W., … Kaufman, F. R. (2018). Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes. Diabetes Technology & Therapeutics.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
Anderson, S. M., Dassau, E., Raghinaru, D., Lum, J., Brown, S. A., Pinsker, J. E., … Kovatchev, B. P. (2019). The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. Diabetes Technology & Therapeutics.

Impact of Early Diabetic Ketoacidosis on the Developing Brain.
Aye, T., Mazaika, P. K., Mauras, N., Marzelli, M. J., Shen, H., Hershey, T., … Reiss, A. L. (2018). Impact of Early Diabetic Ketoacidosis on the Developing Brain. Diabetes Care.

Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes
Triolo, T. M., Fouts, A., Pyle, L., Yu, L., Gottlieb, P. A., Steck, A. K., … Paul, Z. Y. (2019). Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes. DIABETES CARE, 42(2), 192–99.

A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring.
Nally, L. M., Bondy, N., Doiev, J., Buckingham, B., & Wilson, D. M. (2019). A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics.

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.
Forlenza, G. P., Ekhlaspour, L., Breton, M., Maahs, D. M., Wadwa, R. P., DeBoer, M., … Chernavvsky, D. (2019). Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. Diabetes Technology & Therapeutics.

A two center randomized controlled trial of insulin pump therapy in young children with diabetes
Wilson, D., Buckingham, B., Kunselman, E., Sullivan, M., Paguntalan, H., & Gitelman, S. (2003). A two center randomized controlled trial of insulin pump therapy in young children with diabetes. DIABETES, 52, A402.

A 5-center CRC-Based study of the accuracy of the GlucoWatch((R)) G2((TM)) biographer in children and adolescents with type 1 diabetes
Wilson, D., Buckingham, B., Beck, R., Ruedy, K., Kollman, C., Tsalikian, E., … Chase, P. (2003). A 5-center CRC-Based study of the accuracy of the GlucoWatch((R)) G2((TM)) biographer in children and adolescents with type 1 diabetes. DIABETES, 52, A101.

Diabetes research in children network (DirecNet) accuracy study of the continuous glucose monitoring system (CGMS) and Gluco Watch (R) G2 (TM) biographer (GWB) in children with type 1 diabetes - A CRC-based study
Buckingham, B., Beck, R., Tamborlane, W., Ruedy, K., Boland, E., Chase, P., … Kollman, C. (2003). Diabetes research in children network (DirecNet) accuracy study of the continuous glucose monitoring system (CGMS) and Gluco Watch (R) G2 (TM) biographer (GWB) in children with type 1 diabetes - A CRC-based study. DIABETES, 52, A36.

Continuous subcutaneous insulin infusion (CSD) in children under five years of age
Buckingham, B. A., Paguntalan, H., Fassl, B., & Wilson, D. M. (2001). Continuous subcutaneous insulin infusion (CSD) in children under five years of age. DIABETES, 50, A107.

Data entry errors in using the minimed continuous glucose sensor (CGS)
Buckingham, B. A., Paguntalan, H., & Wilson, D. M. (2001). Data entry errors in using the minimed continuous glucose sensor (CGS). DIABETES, 50, A431.

Family assessment of the utility of the DirecNet applied treatment algorithm (DATA) for insulin adjustments in real-tilme and retrospective analyses of continuous glucose monitoring (CGM)
Buckingham, B., Ruedy, K., Kollman, C., Beck, R., Tamborlane, W., Mauras, N., … Tsalikian, E. (2006). Family assessment of the utility of the DirecNet applied treatment algorithm (DATA) for insulin adjustments in real-tilme and retrospective analyses of continuous glucose monitoring (CGM). DIABETES, 55, A453.

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.
Howsmon, D. P., Baysal, N., Buckingham, B. A., Forlenza, G. P., Ly, T. T., Maahs, D. M., … Bequette, B. W. (2018). Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas. Journal of Diabetes Science and Technology, 12(3), 599–607.

A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas
Hirsch, I. B., Balo, A. K., Sayer, K., Garcia, A., Buckingham, B. A., & Peyser, T. A. (2017). A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas. DIABETES TECHNOLOGY & THERAPEUTICS, 19, S38–S48.

Algorithms for a Single Hormone Closed-Loop Artificial Pancreas: Challenges Pertinent to Chemical Process Operations and Control
Bequette, B. W., Cameron, F., Baysal, N., Howsmon, D. P., Buckingham, B. A., Maahs, D. M., & Levy, C. J. (2016). Algorithms for a Single Hormone Closed-Loop Artificial Pancreas: Challenges Pertinent to Chemical Process Operations and Control. PROCESSES, 4(4).

Transient False Positive Elevations of Antibody Markers of Celiac Disease at the Onset of Diabetes
Shanmugham, S., & Buckingham, B. (2012). Transient False Positive Elevations of Antibody Markers of Celiac Disease at the Onset of Diabetes. DIABETES, 61, A320.

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016). Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 316(13), 1407–8.

Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days
DeSalvo, D. J., Ly, T. T., Wadwa, R. P., Messer, L., Westfall, E., Gopisetty, D., … Buckingham, B. A. (2016). Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days. DIABETES CARE, 39(8), E112–E113.

Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp
Ly, T. T., Buckingham, B. A., DeSalvo, D. J., Shanmugham, S., Satin-Smith, M., DeBoer, M. D., … Chernavvsky, D. R. (2016). Day-and-Night Closed-Loop Control Using the Unified Safety System in Adolescents With Type 1 Diabetes at Camp. DIABETES CARE, 39(8), E106–E107.

Effects of Frequency of Sensor-Augmented Pump Use on HbA1c and C-Peptide Levels in the First Year of Type 1 Diabetes.
Triolo, T. M., Maahs, D. M., Pyle, L., Slover, R., Buckingham, B., Cheng, P., … Chase, H. P. (2016). Effects of Frequency of Sensor-Augmented Pump Use on HbA1c and C-Peptide Levels in the First Year of Type 1 Diabetes. Diabetes Care, 39(4), e61–2.

Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes
DeSalvo, D. J., Maahs, D. M., Messer, L., Wadwa, R. P., Payne, S., Ly, T. T., & Buckingham, B. A. (2015). Effect of Lipohypertrophy on Accuracy of Continuous Glucose Monitoring in Patients With Type 1 Diabetes. DIABETES CARE, 38(10), E166–E167.

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
Maahs, D. M., DeSalvo, D., Pyle, L., Trang Ly, Messer, L., Clinton, P., … Buckingham, B. (2015). Effect of Acetaminophen on CGM Glucose in an Outpatient Setting. DIABETES CARE, 38(10), E158–E159.

Effect of Shared Medical Appointments in Youth with Type 1 Diabetes in Poor Control
Shah, A. C., Block, J. M., Floyd, B. D., Evans-Behnke, D., Hendry, D., & Buckingham, B. A. (2014). Effect of Shared Medical Appointments in Youth with Type 1 Diabetes in Poor Control. DIABETES. AMER DIABETES ASSOC.

Effect of Lipohypertrophy on Dexcom G4p Continuous Glucose Sensor
Desalvo, D. J., Ly, T., Clinton, P., Shanmugham, S., & Buckingham, B. A. (2014). Effect of Lipohypertrophy on Dexcom G4p Continuous Glucose Sensor. DIABETES, 63, A221.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes
Forlenza, G. P., Buckingham, B. A., Christiansen, M. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., … Ly, T. T. (2019). Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS.

Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
Forlenza, G. P., Buckingham, B. A., Christiansen, M. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., … Ly, T. T. (2019). Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics.

Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.
Garcia, A., Balo, A. K., Buckingham, B. A., Hirsch, I. B., & Peyser, T. A. (2017). Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data. Diabetes Technology & Therapeutics, 19(12), 699–706.

A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring
Nally, L. M., Bondy, N. W., Doiev, J., Buckingham, B., & Wilson, D. (2018). A Feasibility Study to Detect Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring. DIABETES, 67.

The Impact of Real Time Continuous Glucose Monitoring in the Classroom/School Environment
Aye, T., Block, J. M., Buckingham, B. A., & Wilson, D. M. (2011). The Impact of Real Time Continuous Glucose Monitoring in the Classroom/School Environment. DIABETES, 60, A248.

The Use of Diffusion Tensor Imaging (DTI) in Young Children with Type 1 Diabetes
Aye, T., Barnea-Goraly, N., Park, Y., Wilson, D. M., Reiss, A. L., & Buckingham, B. A. (2011). The Use of Diffusion Tensor Imaging (DTI) in Young Children with Type 1 Diabetes. DIABETES, 60, A44–A45.

A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring
Nally, L. M., Bondy, N., Doiev, J., Buckingham, B. A., & Wilson, D. M. (2019). A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. DIABETES TECHNOLOGY & THERAPEUTICS, 21(4), 170–76.

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management
Adams, R. N., Tanenbaum, M. L., Hanes, S. J., Ambrosino, J. M., Ly, T. T., Maahs, D. M., … Hood, K. K. (2018). Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management. DIABETES TECHNOLOGY & THERAPEUTICS, 20(10), 648–53.

Advances in Care for Insulin-Requiring Patients Without Closed Loop
Lal, R. A., Buckingham, B., & Maahs, D. M. (2018). Advances in Care for Insulin-Requiring Patients Without Closed Loop. DIABETES TECHNOLOGY & THERAPEUTICS, 20, 85–91.

Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
Anderson, S. M., Buckingham, B. A., Breton, M. D., Robic, J. L., Barnett, C. L., Wakeman, C. A., … Kovatchev, B. P. (2019). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. Diabetes Technology & Therapeutics.

Closed Loop Control in Adolescents and Children During Winter Sports: Use of the Tandem Control-IQ AP System.
Ekhlaspour, L., Forlenza, G. P., Chernavvsky, D., Maahs, D. M., Wadwa, R. P., DeBoer, M. D., … Breton, M. D. (2019). Closed Loop Control in Adolescents and Children During Winter Sports: Use of the Tandem Control-IQ AP System. Pediatric Diabetes.

A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.
Ekhlaspour, L., Tabatabai, I., & Buckingham, B. (2019). A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery. Journal of Diabetes Science and Technology, 1932296819851790.

Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations.
Berget, C., Driscoll, K. A., Lagges, A., Lange, S., DiMeglio, L. A., Hannon, T. S., … Buckingham, B. B. (2019). Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations. Contemporary Clinical Trials.

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
Musolino, G., Allen, J. M., Hartnell, S., Wilinska, M. E., Tauschmann, M., Boughton, C., … Hovorka, R. (2019). Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol. BMJ Open, 9(6), e027856.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., … Phillip, M. (2019). Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care.

Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes
Mazaika, P. K., Aye, T., Reiss, A. L., & Buckingham, B. A. (2018). Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes. DIABETES CARE, 41(7), 1535–37.

Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
Lal, R. A., Ekhlaspour, L., Hood, K., & Buckingham, B. (2019). Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes. Endocrine Reviews.

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes
Buckingham, B. A., Christiansen, M. P., Forlenza, G. P., Wadwa, R. P., Peyser, T. A., Lee, J. B., … Ly, T. T. (2018). Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 20(9), 585–95.

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial
Forlenza, G. P., Ekhlaspour, L., Breton, M., Maahs, D. M., Wadwa, R. P., DeBoer, M., … Chernavvsky, D. (2019). Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. DIABETES TECHNOLOGY & THERAPEUTICS, 21(4), 159–69.

The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability
Anderson, S. M., Dassau, E., Raghinaru, D., Lum, J., Brown, S. A., Pinsker, J. E., … Kovatchev, B. P. (2019). The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. DIABETES TECHNOLOGY & THERAPEUTICS, 21(2), 73–80.

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes
Forlenza, G. P., Pinhas-Hamiel, O., Liljenquist, D. R., Shulman, D. I., Bailey, T. S., Bode, B. W., … Kaufman, F. R. (2019). Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes. DIABETES TECHNOLOGY & THERAPEUTICS, 21(1), 11–19.

Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All
Prahalad, P., Addala, A., Buckingham, B., Wilson, D. M., & Maahs, D. M. (2018). Sustained Continuous Glucose Monitor Use in Low-Income Youth with Type 1 Diabetes Following Insurance Coverage Supports Expansion of Continuous Glucose Monitor Coverage for All. DIABETES TECHNOLOGY & THERAPEUTICS, 20(9), 632–34.

Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum
Sang, A. X., Lal, R., August, A., Danzer, E., Buckingham, B., & Mueller, C. M. (2019). Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum. CLINICAL CASE REPORTS.

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system
Ekhlaspour, L., Forlenza, G. P., Chernavvsky, D., Maahs, D. M., Wadwa, R. P., Deboer, M. D., … Breton, M. D. (2019). Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system. PEDIATRIC DIABETES, 20(6), 759–68.

Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.
Ekhlaspour, L., Nally, L. M., El-Khatib, F. H., Ly, T. T., Clinton, P., Frank, E., … Buckingham, B. A. (2019). Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting. Journal of Diabetes Science and Technology, 1932296819872225.

Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum.
Sang, A. X., Lal, R., August, A., Danzer, E., Buckingham, B., & Mueller, C. M. (2019). Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum. Clinical Case Reports, 7(9), 1717–1720.

One Year Clinical Experience of the First Commercial Hybrid Closed-Loop.
Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019). One Year Clinical Experience of the First Commercial Hybrid Closed-Loop. Diabetes Care.

Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
Sherr, J., Buckingham, B. A., Forlenza, G., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., … Ly, T. T. (2019). Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technology & Therapeutics.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., … Beck, R. W. (2019). Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. The New England Journal of Medicine.

Executive task-based brain function in children with type 1 diabetes: An observational study.
Foland-Ross, L. C., Buckingam, B., Mauras, N., Arbelaez, A. M., Tamborlane, W. V., Tsalikian, E., … Reiss, A. L. (2019). Executive task-based brain function in children with type 1 diabetes: An observational study. PLoS Medicine, 16(12), e1002979.

Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries.
Miller, K. M., Hermann, J., Foster, N., Hofer, S. E., Rickels, M. R., Danne, T., … Holl, R. W. (2020). Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries. Diabetes Care, 43(1), e1–e2.

Randomized Controlled Trial of Mobile Closed-Loop Control.
Kovatchev, B., Anderson, S. M., Raghinaru, D., Kudva, Y. C., Laffel, L. M., Levy, C., … Beck, R. W. (2020). Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes Care.

670G Clinical Experience
Lal, R., Basina, M., Maahs, D. M., Buckingham, B. A., Hood, K. K., Conrad, B. P., … Wilson, D. (2019). 670G Clinical Experience. DIABETES. AMER DIABETES ASSOC.

Functional Near-Infrared Spectroscopy (fNIRS) detects increased activation of the brain frontal-parietal network in youth with type 1 diabetes.
Mazaika, P. K., Marzelli, M., Tong, G., Foland-Ross, L. C., Buckingham, B. A., Aye, T., & Reiss, A. L. (2020). Functional Near-Infrared Spectroscopy (fNIRS) detects increased activation of the brain frontal-parietal network in youth with type 1 diabetes. Pediatric Diabetes.

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users
Tanenbaum, M. L., Iturralde, E., Hanes, S. J., Suttiratana, S. C., Ambrosino, J. M., Ly, T. T., … Hood, K. K. (2020). Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users. JOURNAL OF HEALTH PSYCHOLOGY, 25(4), 429–38.

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.
Maikawa, C. L., Smith, A. A., Zou, L., Roth, G. A., Gale, E. C., Stapleton, L. M., … Appel, E. A. (2020). A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs. Nature Biomedical Engineering.

Brain Function Differences in Children With Type 1 Diabetes: An fMRI Study of Working Memory.
Foland-Ross, L. C., Tong, G., Mauras, N., Cato, A., Aye, T., Tansey, M., … Reiss, A. L. (2020). Brain Function Differences in Children With Type 1 Diabetes: An fMRI Study of Working Memory. Diabetes.

Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System.
Hsu, L. J., Buckingham, B. A., Basina, M., Ekhlaspour, L., von Eyben, R., Wang, J., & Lal, R. A. (2020). Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System. Diabetes Technology & Therapeutics.

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.
Brown, S. A., Beck, R. W., Raghinaru, D., Buckingham, B. A., Laffel, L. M., Wadwa, R. P., … Kovatchev, B. P. (2020). Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial. Diabetes Care, 43(8), 1822–28.

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., … Wadwa, R. P. (2020). A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. The New England Journal of Medicine, 383(9), 836–45.

Clinically Significant Hypoglycemia Is Rare in Youth with T1D during Partial Clinical Remission
Addala, A., Gu, A., Zaharieva, D., Prahalad, P., Buckingham, B. A., Scheinker, D., & Maahs, D. M. (2020). Clinically Significant Hypoglycemia Is Rare in Youth with T1D during Partial Clinical Remission. DIABETES. AMER DIABETES ASSOC.

Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.
Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., … Klonoff, D. C. (2020). Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. Journal of Diabetes Science and Technology, 1932296820954163.

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Moser, O., Riddell, M. C., Eckstein, M. L., Adolfsson, P., Rabasa-Lhoret, R., van den Boom, L., … Mader, J. K. (2020). Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Pediatric Diabetes.

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Moser, O., Riddell, M. C., Eckstein, M. L., Adolfsson, P., Rabasa-Lhoret, R., van den Boom, L., … Mader, J. K. (2020). Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia.

Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-loop Control System: Results from a 6-month Multicenter Randomized Clinical Trial.
O'Malley, G., Messer, L. H., Levy, C., Pinsker, J. E., Forlenza, G. P., Isganaitis, E., … Brown, S. (2020). Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-loop Control System: Results from a 6-month Multicenter Randomized Clinical Trial. Diabetes Technology & Therapeutics.

Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.
Cortez, F. de, Gebhart, D., Robinson, P. V., Seftel, D., Pourmandi, N., Owyoung, J., … Tsai, C.-T. (2020). Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR. PloS One, 15(11), e0242049.

Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial.
Isganaitis, E., Raghinaru, D., Ambler-Osborn, L., Pinsker, J. E., Buckingham, B. A., Wadwa, R. P., … Laffel, L. M. (2020). Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop (iDCL) Trial. Diabetes Technology & Therapeutics.

Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers.
Ekhlaspour, L., Schoelwer, M. J., Forlenza, G. P., DeBoer, M. D., Norlander, L., Hsu, L. J., … Wadwa, R. P. (2020). Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technology & Therapeutics.

Glucose Management during physical Activity/Sport by Using continuous Glucose Meters (CGM/isCGM) in Type 1 Diabetes - EASD/ISPAD Position Statement, supported by ADA and JDRF
Moser, O., Riddell, M. C., Eckstein, M. L., Adolfsson, P., Rabasa-Lhoret, R., van den Boom, L., … Mader, J. K. (2020). Glucose Management during physical Activity/Sport by Using continuous Glucose Meters (CGM/isCGM) in Type 1 Diabetes - EASD/ISPAD Position Statement, supported by ADA and JDRF. WIENER KLINISCHE WOCHENSCHRIFT, 132(SUPPL 6), S340–S341.

First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes.
Forlenza, G. P., Buckingham, B. A., Brown, S., Bode, B. W., Levy, C., Criego, A., … Ly, T. T. (2020). First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. Diabetes Technology & Therapeutics.

Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.
Kanapka, L. G., Wadwa, R. P., Breton, M. D., Ruedy, K. J., Ekhlaspour, L., Forlenza, G. P., … Beck, R. W. (2020). Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes Care.

Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
Cobry, E., Kanapka, L., Cengiz, E., Carria, L., Ekhlaspour, L., Buckingham, B. A., … Wadwa, R. P. (2021). Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technology & Therapeutics.

Engineering biopharmaceutical formulations to improve diabetes management.
Maikawa, C. L., d'Aquino, A. I., Lal, R. A., Buckingham, B. A., & Appel, E. A. (2021). Engineering biopharmaceutical formulations to improve diabetes management. Science Translational Medicine, 13(578).

Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study.
Mauras, N., Buckingham, B., White, N. H., Tsalikian, E., Weinzimer, S. A., Jo, B., … Reiss, A. L. (2021). Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study. Diabetes Care.

Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System.
Schoelwer, M. J., Kanapka, L. G., Wadwa, R. P., Breton, M. D., Ruedy, K. J., Ekhlaspour, L., … DeBoer, M. D. (2021). Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technology & Therapeutics.

Advances in Insulin Pump Infusion Sets Symposium Report.
Zhang, J. Y., Shang, T., Chattaraj, S., Cohen, O., Heschel, M., Vigersky, R. A., … Klonoff, D. C. (2021). Advances in Insulin Pump Infusion Sets Symposium Report. Journal of Diabetes Science and Technology, 1932296821999080.

Longevity of the Novel ConvaTec Infusion Set with Lantern Technology.
Lal, R. A., Hsu, L., Zhang, J., Schondorff, P. K., Heschel, M., & Buckingham, B. (2021). Longevity of the Novel ConvaTec Infusion Set with Lantern Technology. Diabetes, Obesity & Metabolism.

Full closed loop open-source algorithm performance comparison in pigs with diabetes.
Lal, R. A., Maikawa, C. L., Lewis, D., Baker, S. W., Smith, A. A., Roth, G. A., … Appel, E. A. (2021). Full closed loop open-source algorithm performance comparison in pigs with diabetes. Clinical and Translational Medicine, 11(4), e387.

"IT'S LIKE LEARNING TO DRIVE A MANUAL CAR": EXPERIENCES OF CONTINUOUS GLUCOSE MONITORING ADOPTION IN ADULTS WITH TYPE 1 DIABETES
Wu, C. A., Tanenbaum, M. L., Ngo, J., Hood, K., Hanes, S., Basina, M., … Maahs, D. M. (2021). "IT'S LIKE LEARNING TO DRIVE A MANUAL CAR": EXPERIENCES OF CONTINUOUS GLUCOSE MONITORING ADOPTION IN ADULTS WITH TYPE 1 DIABETES. ANNALS OF BEHAVIORAL MEDICINE. OXFORD UNIV PRESS INC.

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.
Brown, S. A., Forlenza, G. P., Bode, B. W., Pinsker, J. E., Levy, C. J., Criego, A. B., … Ly, T. T. (2021). Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care.

Patient Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed Loop Trial.
Kudva, Y. C., Laffel, L. M., Brown, S., Raghinaru, D., Pinsker, J. E., Ekhlaspour, L., … Gonder-Frederick, L. A. (2021). Patient Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed Loop Trial. Diabetes Technology & Therapeutics.

ONBOARD: A feasibility study of a telehealth-based continuous glucose monitoring adoption intervention for adults with type 1 diabetes.
Tanenbaum, M., Ngo, J., Hanes, S., Basina, M., Buckingham, B. A., Hessler, D., … Hood, K. (2021). ONBOARD: A feasibility study of a telehealth-based continuous glucose monitoring adoption intervention for adults with type 1 diabetes. Diabetes Technology & Therapeutics.

Clinically serious hypoglycemia is rare and not associated with time-in-range in youth with new-onset type 1 diabetes.
Addala, A., Zaharieva, D. P., Gu, A. J., Prahalad, P., Scheinker, D., Buckingham, B., … Maahs, D. M. (2021). Clinically serious hypoglycemia is rare and not associated with time-in-range in youth with new-onset type 1 diabetes. The Journal of Clinical Endocrinology and Metabolism.

Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
Maikawa, C. L., Chen, P. C., Vuong, E. T., Nguyen, L. T., Mann, J. L., d'Aquino, A. I., … Appel, E. A. (2021). Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), e2101575.

Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.
Tanenbaum, M. L., Messer, L. H., Wu, C. A., Basina, M., Buckingham, B. A., Hessler, D., … Hood, K. K. (2021). Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM. Diabetes Research and Clinical Practice, 109048.

Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study.
Forlenza, G. P., Vigers, T., Berget, C., Messer, L., Lal, R. A., Basina, M., … Pyle, L. (2021). Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study. Diabetes Technology & Therapeutics.

Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study.
Bisio, A., Anderson, S., Norlander, L., O'Malley, G., Robic, J., Ogyaadu, S., … Breton, M. D. (2021). Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care.

Corrigendum to: Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline.
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2021). Corrigendum to: Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism.

Glycemic Outcomes of Children 2-6Years of Age with Type 1 Diabetes during the Pediatric MiniMed 670G System Trial.
Forlenza, G. P., Ekhlaspour, L., DiMeglio, L. A., Fox, L. A., Rodriguez, H., Shulman, D. I., … Buckingham, B. A. (1800). Glycemic Outcomes of Children 2-6Years of Age with Type 1 Diabetes during the Pediatric MiniMed 670G System Trial. Pediatric Diabetes.

Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop (iDCL) Trial.
Ekhlaspour, L., Town, M. A., Raghinaru, D., Lum, J., Brown, S., & Buckingham, B. A. (2022). Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop (iDCL) Trial. Diabetes Technology & Therapeutics.

Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies.
Cortez, F. de, Gebhart, D., Tandel, D., Robinson, P. V., Seftel, D., Wilson, D. M., … Tsai, C.-T. (1800). Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies. SLAS Technology.

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report.
Nguyen, K. T., Xu, N. Y., Buckingham, B. A., Chattaraj, S., Cohen, O., Heinemann, L., … Ziegler, R. (2022). Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report. Journal of Diabetes Science and Technology, 19322968221078884.

Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial.
Ware, J., Boughton, C. K., Allen, J. M., Wilinska, M. E., Tauschmann, M., Denvir, L., … Hovorka, R. (2022). Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. The Lancet. Digital Health.

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.
Brazg, R. L., Garg, S. K., Bhargava, A., Thasher, J. R., Latif, K., Bode, B. W., … Buckingham, B. A. (2022). Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial. Diabetes Technology & Therapeutics.

Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop (iDCL) Trial.
Ekhlaspour, L., Raghinaru, D., Forlenza, G. P., Isganaitis, E., Kudva, Y. C., Lam, D. W., … Brown, S. A. (2022). Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop (iDCL) Trial. Journal of Diabetes Science and Technology, 19322968221089361.

Smartwatch Gesture-Based Meal Reminders Improve Glycemic Control.
Corbett, J. P., Hsu, L., Brown, S. A., Kollar, L., Vleugels, K., Buckingham, B., … Lal, R. A. (2022). Smartwatch Gesture-Based Meal Reminders Improve Glycemic Control. Diabetes, Obesity & Metabolism.

Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation versus Sensor-Augmented Pump: Results from the International Diabetes Closed Loop Trial 4 (DCLP4).
Pinsker, J. E., Dassau, E., Deshpande, S., Raghinaru, D., Buckingham, B. A., Kudva, Y. C., … Doyle Iii, F. J. (2022). Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation versus Sensor-Augmented Pump: Results from the International Diabetes Closed Loop Trial 4 (DCLP4). Diabetes Technology & Therapeutics.

Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes.
Buckingham, B., Sherr, J., Prestrelski, S. J., & Conoscenti, V. (2022). Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes. Pediatric Diabetes.

Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.
Sherr, J. L., Bode, B. W., Forlenza, G. P., Laffel, L. M., Schoelwer, M. J., Buckingham, B. A., … Ly, T. T. (2022). Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care.

Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
Messer, L. H., Buckingham, B. A., Cogen, F., Daniels, M., Forlenza, G. P., Jafri, R., … Beck, R. W. (2022). Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technology & Therapeutics.

Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.
Hood, K. K., Garcia-Willingham, N., Hanes, S., Tanenbaum, M. L., Ware, J., Boughton, C. K., … Hovorka, R. (2022). Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents. Diabetes, Obesity & Metabolism.

A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes.
Reiss, A. L., Jo, B., Arbelaez, A. M., Tsalikian, E., Buckingham, B., Weinzimer, S. A., … Mauras, N. (2022). A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes. Nature Communications, 13(1), 4940.

Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice.
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., … Battelino, T. (2022). Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine Reviews.

Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
Russell, S. J., Beck, R. W., Damiano, E. R., El-Khatib, F. H., Ruedy, K. J., Balliro, C. A., … Dauber, A. (2022). Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. The New England Journal of Medicine, 387(13), 1161–1172.

Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
Messer, L. H., Buckingham, B. A., Cogen, F., Daniels, M., Forlenza, G., Jafri, R. Z., … Beck, R. W. (2022). Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technology & Therapeutics, 24(10), 712–725.

Improved Glycemia with Hybrid Closed-Loop (HCL) Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results from a Randomized Controlled Trial.
Garg, S. K., Grunberger, G., Weinstock, R. S., Lawson, M. L., Hirsch, I. B., DiMeglio, L. A., … Vigersky, R. A. (2022). Improved Glycemia with Hybrid Closed-Loop (HCL) Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results from a Randomized Controlled Trial. Diabetes Technology & Therapeutics.

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Battelino, T., Alexander, C. M., Amiel, S. A., Arreaza-Rubin, G., Beck, R. W., Bergenstal, R. M., … Phillip, M. (2022). Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. The Lancet. Diabetes & Endocrinology.

ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes.
Frohlich-Reiterer, E., Elbarbary, N. S., Simmons, K., Buckingham, B., Humayun, K. N., Johannsen, J., … Mahmud, F. H. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatric Diabetes, 23(8), 1451–1467.

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
Forlenza, G. P., McVean, J., Beck, R. W., Bauza, C., Bailey, R., Buckingham, B., … Moran, A. (2023). Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA.

Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
McVean, J., Forlenza, G. P., Beck, R. W., Bauza, C., Bailey, R., Buckingham, B., … Moran, A. (2023). Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA.

Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., … Breton, M. D. (2023). Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. The New England Journal of Medicine, 388(11), 991–1001.

A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.
Beck, R. W., Kanapka, L. G., Breton, M. D., Brown, S. A., Wadwa, R. P., Buckingham, B. A., … Kovatchev, B. (2023). A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72. Diabetes Technology & Therapeutics.

Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes.
Zaharieva, D. P., Morrison, D., Paldus, B., Lal, R. A., Buckingham, B. A., & O'Neal, D. N. (2023). Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes. Diabetes Spectrum : a Publication of the American Diabetes Association, 36(2), 127–136.

Glycemic outcomes during early use of the MiniMed 780G advanced hybrid closed-loop system with Guardian 4 sensor.
Cordero, T. L., Dai, Z., Arrieta, A., Niu, F., Vella, M., Shin, J., … Vigersky, R. A. (2023). Glycemic outcomes during early use of the MiniMed 780G advanced hybrid closed-loop system with Guardian 4 sensor. Diabetes Technology & Therapeutics.

Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water.
Hughes, M. S., Kingman, R. S., Hsu, L., Lal, R. A., Buckingham, B. A., & Zaharieva, D. P. (2023). Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water. Diabetes Care.

Psychosocial Outcomes with the Omnipod & REG; 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers
Hood, K. K., Polonsky, W. H., MacLeish, S. A., Levy, C. J., Forlenza, G. P., Criego, A. B., … Ly, T. T. (2023). Psychosocial Outcomes with the Omnipod & REG; 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. PEDIATRIC DIABETES, 2023.

Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply.
Forlenza, G. P., Schamberger, M. S., & Buckingham, B. A. (2023). Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply. JAMA, 330(4), 380.

Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multi-Center, Single-arm, Feasibility Trial.
Davis, G. M., Hughes, M. S., Brown, S., Sibayan, J., Perez-Guzman, M. C., Stumpf, M., … Pasquel, F. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multi-Center, Single-arm, Feasibility Trial. Diabetes Technology & Therapeutics.

Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop (AHCL) system pivotal trial in children and adolescents with type 1 diabetes.
Pihoker, C., Shulman, D. I., Forlenza, G. P., Kaiserman, K. B., Sherr, J. L., Thasher, J. R., … Vigersky, R. A. (2023). Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop (AHCL) system pivotal trial in children and adolescents with type 1 diabetes. Diabetes Technology & Therapeutics.

Two Years with a Tubeless AID System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes.
Criego, A., Carlson, A. L., Brown, S., Forlenza, G. P., Bode, B., Levy, C., … Ly, T. T. (2023). Two Years with a Tubeless AID System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics.

Diabetic ketoacidosis (DKA) at diagnosis in youth with type 1 diabetes (T1D) is associated with a higher hemoglobin A1c even with intensive insulin management.
Zaharieva, D. P., Ding, V., Addala, A., Prahalad, P., Bishop, F., Hood, K., … Maahs, D. M. (2023). Diabetic ketoacidosis (DKA) at diagnosis in youth with type 1 diabetes (T1D) is associated with a higher hemoglobin A1c even with intensive insulin management. Diabetes Technology & Therapeutics.

Digital Technology for Diabetes.
Hughes, M. S., Addala, A., & Buckingham, B. (2023). Digital Technology for Diabetes. The New England Journal of Medicine, 389(22), 2076–2086.

Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod 5 Automated Insulin Delivery System.
DeSalvo, D. J., Bode, B., Forlenza, G. P., Laffel, L. M., Buckingham, B. A., Criego, A., … Ly, T. T. (2024). Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod 5 Automated Insulin Delivery System. Diabetes Technology & Therapeutics.

Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology.
Hood, K. K., Schneider-Utaka, A. K., Reed, Z. W., Buckingham, B. A., Cobry, E., DeBoer, M. D., … Breton, M. D. (2024). Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology. Diabetes Research and Clinical Practice, 208, 111114.

Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study.
Buckingham, B. A., & Bergenstal, R. M. (2024). Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study. Diabetes Technology & Therapeutics, 26(S3), 97–101.

Digital Technology for Diabetes. Reply.
Hughes, M. S., Addala, A., & Buckingham, B. (2024). Digital Technology for Diabetes. Reply. The New England Journal of Medicine, 390(10), 963–964.

The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions.
Faggionato, E., Schiavon, M., Ekhlaspour, L., Buckingham, B. A., & Dalla Man, C. (2024). The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions. IEEE Transactions on Bio-Medical Engineering, 71(3), 977–986.

Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial.
Fox, D. S., Ware, J., Boughton, C. K., Allen, J. M., Wilinska, M. E., Tauschmann, M., … Hovorka, R. (2024). Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial. Journal of Diabetes Science and Technology, 19322968241231950.

Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based, Cohort Study.
Laugesen, C., Ritschel, T., Ranjan, A., Hsu, L. J., Jørgensen, J. B., Svensson, J., … Norgaard, K. (2024). Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based, Cohort Study. Diabetes Technology & Therapeutics.

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience.
Ekhlaspour, L., Buckingham, B., Bauza, C., Clements, M., Forlenza, G. P., Neyman, A., … Moran, A. (2024). Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience. Journal of Clinical & Translational Endocrinology, 36, 100352.